Clinical trial
A Novel Risk System Integrating Clustering-derived Subtype and TyG Index for Predicting Postoperative Delirium in Colorectal Cancer Patients
NCT07597330 is registered in ClinicalTrials.gov with LanZhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Novel Risk System Integrating Clustering-derived Subtype and TyG Index for Predicting Postoperative Delirium in Colorectal Cancer Patients
- Lead sponsor
- LanZhou University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2024
- Completion date
- September 1, 2025
- Enrollment
- 590 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer (msi-h), postoperative delirium (pod)